IRBESARTAN TERAPIA 150mg tablets medication leaflet

C09CA04 irbesartan • Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain

Irbesartan is a medication used to treat high blood pressure and diabetic nephropathy in patients with type 2 diabetes. It belongs to the class of angiotensin II receptor antagonists and works by relaxing blood vessels, thereby lowering blood pressure.

The medication is taken orally, usually once daily, as directed by a doctor.

Side effects may include dizziness, fatigue, nausea, or increased potassium levels in the blood. In rare cases, severe allergic reactions or kidney dysfunction may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.

General data about IRBESARTAN TERAPIA 150mg

Substance: irbesartan

Date of last drug list: 01-06-2025

Commercial code: W54081003

Concentration: 150mg

Pharmaceutical form: tablets

Quantity: 28

Product type: generic

Price: 23.24 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: TERAPIA SA - ROMANIA

Holder: TERAPIA S.A. - ROMANIA

Number: 6306/2014/03

Shelf life: 3 years

Pharmaceutical forms available for irbesartan

Concentrations available for irbesartan

150mg, 300mg, 7.5mg, 75mg

Compensation lists for IRBESARTAN TERAPIA 150mg TERAPIA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

23.24 RON

11.62 RON

11.62 RON

G25 (C1) - Chronic renal failure

Price

Copayment

Patient

23.24 RON

19.20 RON

4.04 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

23.24 RON

19.20 RON

4.04 RON